Abstract
In previous study, we have found the catechol-O-methyltransferase (COMT) Val158Met polymorphism as an associated risk factor for Parkinson’s disease (PD) in Asian rather than Caucasian populations. The aim of this study was to further evaluate the associations of PD risk with COMT polymorphisms in different Asian populations. We carried out a retrieval of studies that investigated associations between COMT Val158Met polymorphism and PD risk in Asians, and included the study if it met the eligibility criteria. Stata version 12.0 was used to analyze the data. A total of 13 studies including 1,834 patients and 2,298 controls were included. The overall result indicated that COMT Val158Met polymorphism was significantly associated with the risk of PD in Asians (AA vs others: OR = 1.58, 95 % CI 1.26–1.97, p < 0.001; GG vs AA: OR = 0.63, 95 % CI 0.47–0.85, p = 0.002; AA vs GA: OR = 1.58, 95 % CI 1.24–2.00, p < 0.001). In Japanese population, the homozygote AA tends to increase the risk of PD (AA vs others: OR = 1.54, 95 % CI 1.10–2.15, p = 0.012; AA vs GA: OR = 1.61, 95 % CI 1.14–2.29, p = 0.008). This study showed that the Val158Met polymorphism of COMT gene may be associated with PD in Japanese rather than Chinese population. Further studies are needed to confirm this association in more ethnicities.
Similar content being viewed by others
References
Massano J, Bhatia KP (2012) Clinical approach to Parkinson’s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2:a008870
Tian YY, Tang CJ, Wu J, Zhou JS (2011) Parkinson’s disease in China. Neurol Sci 32(1):23–30
Trinh J, Farrer M (2013) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9(8):445–454
Samii A, Nutt JG, Ransom BR (2004) Parkinson’s disease. Lancet 363(9423):1783–1793
Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R (2013) Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson’s disease in South Indian subjects. Indian J Biochem Biophys 50(5):436–441
Lu L, Su Y, Hou P, Huang C (2013) The COMT Val158Met polymorphism as an associated risk factor for Parkinson’s disease in Asian rather than Caucasian populations. Neurol India 61:12–16
Tosato S, Bonetto C, Di Forti M, Collier D, Cristofalo D, Bertani M et al (2011) Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients. Neurosci Lett 495(1):17–21
Torkaman-Boutorabi A, Ali Shahidi G, Choopani S, Reza Zarrindast M (2012) Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson’s disease in an Iranian population. Folia Neuropathol 50(4):382–389
Qi D, Dai YP, Chen XG, Li J, Zhang CY (2013) Research on relationship between COMT gene exon four and Parkinson’s genetic susceptibility. Clin J Chin Med 5(21):87–88
Kumudini N, Uma A, Naushad SM, Mridula R, Borgohain R, Kutala VK (2014) Sexual dimorphism in xenobiotic genetic variants-mediated risk for Parkinson’s disease. Neurol Sci 35(6):897–903
Xie T, Ho SL, Li LS, Ma OC (1997) G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson’s disease. Mov Disord 12:426–427
Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, Hoda F et al (1997) High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson’s disease. Neurosci Lett 221:202–204
Yoritaka A, Hattori N, Yoshino H, Mizuno Y (1997) Catechol-O-methyltransferase genotype and susceptibility to Parkinson’s disease in Japan. Short communication. J Neural Transm 104:1313–1317
Mizuta I, Mizuta E, Yamasaki S, Kuno S, Yasuda M, Tanaka C (2000) Meta-analysis of polymorphism of the catechol-O-methyltransferase gene in relation to the etiology of Parkinson’s disease in Japan. Mov Disord 15:1013–1014
Wu RM, Cheng CW, Chen KH, Lu SL, Shan DE, Ho YF et al (2001) The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Neurology 56:375–382
Lee MS, Lyoo CH, Ulmanen I, Syvänen AC, Rinne JO (2001) Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson’s disease. Neurosci Lett 298:131–134
Xu L, Hao YX, Xie HJ, Tang GM, Ren DP (2002) Catecholamine-O-methyltransferase (COMT) gene polymorphism and the risk of Parkinson’s disease in Shanghai Han population. Chin J Med Genet 19:440–441
Watanabe M, Harada S, Nakamura T, Ohkoshi N, Yoshizawa K, Hayashi A et al (2003) Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson’s disease. Neuropsychobiology 48:190–193
Shao M, Liu Z, Tao E, Chen B (2005) Correlation between the genetic polymorphism of dopamine metabolic enzymes and the genetic susceptibility of Parkinson’s disease. J Gerontol 25:743–745
Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K et al (2011) Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson’s disease in a Japanese population. BMC Neurol 11:89
Grossman MH, Emanuel BS, Budarf ML (1992) Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1q11.2. Genomics 12:822–825
Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A et al (1996) No association between Parkinson’s disease and low-activity alleles of catechol O-methyltransferase. Biochem Biophys Res Commun 228:780–784
Lee YH, Song GG (2014) COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer’s disease: a meta-analysis. Neurol Sci 35(5):643–651
Tan EK, Chai A, Lum SY, Shen H, Tan C, Teoh ML et al (2003) Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson’s disease: a study in an Asian population. Am J Med Genet B Neuropsychiatr Genet 120B(1):58–62
Goudreau JL, Maraganore DM, Farrer MJ, Lesnick TG, Singleton AB, Bower JH et al (2002) Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson’s disease. Mov Disord 17:1305–1311
Hernán MA, Checkoway H, O’Brien R, Costa-Mallen P, De Vivo I, Colditz GA et al (2002) MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58:1381–1387
Acknowledgments
This study was supported by the Undergraduate Innovative Experiment Project of Kunming Medical University (No. CX201415). We kindly thank the editors and reviewers for their helps. We also thank all authors in the reference for their original works.
Conflict of interest
We state explicitly there no potential conflicts exist.
Author information
Authors and Affiliations
Corresponding authors
Additional information
L. Chuan, J. Gao and Y. Lei contributed equally to this manuscript.
Rights and permissions
About this article
Cite this article
Chuan, L., Gao, J., Lei, Y. et al. Val158Met polymorphism of COMT gene and Parkinson’s disease risk in Asians. Neurol Sci 36, 109–115 (2015). https://doi.org/10.1007/s10072-014-1896-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-014-1896-0